Indication

Chronic Ocular Graft-versus-host Disease

1 clinical trial

2 products

Clinical trial

Treatment Safety and Efficacy Using Pro-ocular™ 1% for Chronic Ocular Graft-versus-host Disease (GvHD) Following Allogeneic Hematopoietic Stem Cell Transplantation.

Status: Completed, Estimated PCD: 2021-10-31

Product

Product